DOI . ORG {
}
We began analyzing https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT, but it redirected us to https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT. The analysis below is for the second page.
Title[redir]:
Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inh | OTT
Description:
Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway Yan Huang, Sun Wu, Yuan Zhang, Lihua Wang, Yan Guo Department of Hematology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People’s Republic of China Introduction: T-cell lymphoblastic lymphoma (T-LBL) is a widely disseminated disease worldwide. Triptolide (TPL) is purified from Chinese herb and displays anti-inflammatory, anti-fertility, anti-tumor and immunosuppressive effects. Materials and methods: Here, in vitro and in vivo experiments were conducted to investigate the anti-tumor effect of TPL treatment in T-LBL and the potential mechanism in T-LBL progression. Results: TPL inhibited cell proliferation of T-LBL cells (Jurkat cells and Molt-3 cells) in a dose-dependent manner. Flow cytometry analysis showed that cell apoptosis rate was increased by TPL treatment. TPL also up-regulated the expression of Caspase-3, Bax and down-regulated the expression of Bcl-2, indicating that TPL promoted apoptosis in Jurkat cells. Moreover, TPL inhibited invasion ability of Jurkat cells and down-regulated the expression of MMP-3 and MMP-9 in a dose-dependent manner. The expression of Snail, Slug, Twist and Integrin αVβ6 was decreased and the expression of E-cadherin was increased by TPL treatment, indicating that TPL inhibited EMT of Jurkat cells. Apart from that, TPL treatment attenuated the phoslevels of PI3K, Akt and mTOR and suppressed AKT activation compared with control group, suggesting that TPL inhibited PI3K/Akt/mTOR signal pathway in T-LBL. In vivo experiments showed that TPL inhibited tumor growth of T-LBL and promoted apoptosis of tumor cells. The expression of PCNA, Bcl-2, Snail, p-PI3K, p-Akt and mTOR was suppressed by TPL in a dose-dependent manner, suggesting that TPL suppressed tumor growth and promoted apoptosis of tumor cells by inhibiting PI3K/Akt/mTOR signal pathway in T-LBL. Conclusion: In conclusion, TPL exerted anti-tumor effect in T-LBL by inhibiting cell viability, invasion and EMT via regulating the PI3K/AKT/mTOR pathway. Keywords: triptolide, T-cell lymphoblastic lymphoma, invasion, EMT, PI3K/AKT/mTOR
Title[redir]:
Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inh | OTT
Description:
Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway Yan Huang, Sun Wu, Yuan Zhang, Lihua Wang, Yan Guo Department of Hematology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People’s Republic of China Introduction: T-cell lymphoblastic lymphoma (T-LBL) is a widely disseminated disease worldwide. Triptolide (TPL) is purified from Chinese herb and displays anti-inflammatory, anti-fertility, anti-tumor and immunosuppressive effects. Materials and methods: Here, in vitro and in vivo experiments were conducted to investigate the anti-tumor effect of TPL treatment in T-LBL and the potential mechanism in T-LBL progression. Results: TPL inhibited cell proliferation of T-LBL cells (Jurkat cells and Molt-3 cells) in a dose-dependent manner. Flow cytometry analysis showed that cell apoptosis rate was increased by TPL treatment. TPL also up-regulated the expression of Caspase-3, Bax and down-regulated the expression of Bcl-2, indicating that TPL promoted apoptosis in Jurkat cells. Moreover, TPL inhibited invasion ability of Jurkat cells and down-regulated the expression of MMP-3 and MMP-9 in a dose-dependent manner. The expression of Snail, Slug, Twist and Integrin αVβ6 was decreased and the expression of E-cadherin was increased by TPL treatment, indicating that TPL inhibited EMT of Jurkat cells. Apart from that, TPL treatment attenuated the phoslevels of PI3K, Akt and mTOR and suppressed AKT activation compared with control group, suggesting that TPL inhibited PI3K/Akt/mTOR signal pathway in T-LBL. In vivo experiments showed that TPL inhibited tumor growth of T-LBL and promoted apoptosis of tumor cells. The expression of PCNA, Bcl-2, Snail, p-PI3K, p-Akt and mTOR was suppressed by TPL in a dose-dependent manner, suggesting that TPL suppressed tumor growth and promoted apoptosis of tumor cells by inhibiting PI3K/Akt/mTOR signal pathway in T-LBL. Conclusion: In conclusion, TPL exerted anti-tumor effect in T-LBL by inhibiting cell viability, invasion and EMT via regulating the PI3K/AKT/mTOR pathway. Keywords: triptolide, T-cell lymphoblastic lymphoma, invasion, EMT, PI3K/AKT/mTOR
Matching Content Categories {📚}
- Science
- Education
- Insurance
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🏙️ Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 75,586,609 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We can't figure out the monetization strategy.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be making money, but it's not detectable how they're doing it.
Keywords {🔍}
images, figure, press, medical, authors, article, dove, retracted, pathway, wang, duplicated, work, published, open, research, learn, cell, huang, inhibits, han, cancer, terms, informa, reprints, access, journals, peer, review, invasion, epithelialmesenchymal, transition, permission, guo, publication, suppressing, wntβcatenin, group, plc, contact, testimonials, favored, author, login, scientific, editorial, policies, guidelines, papers, manuscript, oncotargets,
Topics {✒️}
activates wnt/β-catenin pathway t-cell lymphoblastic lymphoma wnt/β-catenin pathway editorial policies including fast-track processing ox-ldl-treated raw264 dove medical press suppressing epithelial-mesenchymal transition suppressing epithelial–mesenchymal transition manuscript login favored authors epithelial–mesenchymal transition cope guidelines inhibiting cell viability renal cell carcinoma biophysical research communications mir-361-5p inhibits clinical cancer therapeutics specific author offer real benefits onco targets ther resveratrol enhances chemosensitivity academic publishing division london sw1p 1wg uk vat group gastric cancer cells papers review regulating mir-130b provide satisfactory data author author informa plc articles published medical journals published work h19 inhibits breast cancer suppressing glycolysis retracted article published approved publication control group full terms satisfactory explanation editor scientific journal alerts pharmaceutical industry antitumor effect
Questions {❓}
- Why publish with us?
Social Networks {👍}(9)
- https://www.facebook.com/DoveMedicalPress
- https://twitter.com/DovePress
- https://www.linkedin.com/company/dove-medical-press
- https://www.youtube.com/user/dovepress
- https://www.instagram.com/dovemedicalpress/
- https://twitter.com/intent/tweet?text=Antitumor+effect+of+triptolide+in+T-cell+lymphoblastic+lymphoma+by+inh+%7C+OTT+%40DovePress&related=DovePress&url=https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT
- https://www.facebook.com/sharer.php?u=https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT&t=Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inh | OTT
- https://www.linkedin.com/shareArticle?mini=true&url=https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT&title=Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inh | OTT&source=Dove Press
- https://www.reddit.com/submit?url=https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT
External Links {🔗}(53)
- How much money does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/browse_journals.php generate?
- Get to know what's the income of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/about-us
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/editorial-policies net monthly?
- What's the financial gain of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/author-guidelines?
- How much profit does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/peer-review-guidelines make?
- What are the earnings of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/open_outlook.php?
- What's the total monthly financial gain of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/browse_hot_topics.php?
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/podcasts earn?
- https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/blog's revenue stream
- Revenue of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/bulk_reprints.php
- How profitable is https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/submit_step_1.php?
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/# gross monthly?
- How much revenue does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/contact bring in?
- Get to know what's the income of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/sustainability.php
- What's the financial outcome of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/press-releases?
- https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/why-publish-with-dove-press/testimonials income
- How much revenue does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/why-publish-with-dove-press/favored-authors generate?
- What's the monthly money flow for https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/permissions.php?
- What's the monthly income of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/presubmission_check.php?
- What's the financial outcome of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/login.php?
- What's the income generated by http://www.dovepress.com.cn each month?
- Monthly income for https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/index.php
- Get to know https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/search_advance.php's earnings
- What's the profit of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/editorial_policies.php?
- Get to know https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/script_status.php's earnings
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/register.php rake in every month?
- How much does https://www.dovepress.com/about_dovepress.php rake in every month?
- What's the revenue for https://www.dovepress.com/why-publish-with-dove-press/open-access/?
- Get to know https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/fav_author.php's earnings
- What's https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/oncotargets-and-therapy-journal's gross income?
- https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/oncotargets-and-therapy-archive23-v1272 income
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/qr.php?p=https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT bring in each month?
- What's the profit of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/mailto:?subject=Open Access article on Dove Medical Press&body=Check out this article: https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT?
- What's the profit of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/article_metric.php?article_id=36752?
- What is the monthly revenue of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/get_permissions.php?a_id=36752?
- What's the monthly income of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/author_profile.php?id=852379?
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/author_profile.php?id=852314 make?
- How much revenue does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/author_profile.php?id=852380 bring in?
- What is the monthly revenue of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/author_profile.php?id=852381?
- How much income is https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/author_profile.php?id=852382 earning monthly?
- How much does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/public_profile.php?id=164990 bring in each month?
- How much income does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/article/download/36752 have?
- What's the financial intake of https://www.dovepress.com/retraction-antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymp-peer-reviewed-fulltext-article-OTT?
- What's the financial gain of https://www.dovepress.com/terms.php?
- https://creativecommons.org/licenses/by-nc/3.0/ income
- How much does https://www.informa.com/privacy-policy/ rake in every month?
- Get to know what's the income of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/partners.php
- Learn about the earnings of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/terms.php
- Find out how much https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/cookies.php earns monthly
- What's the total monthly financial gain of https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/#page-top?
- How much cash flow does https://www.dovepress.com/antitumor-effect-of-triptolide-in-t-cell-lymphoblastic-lymphoma-by-inh-peer-reviewed-fulltext-article-OTT/privacy.php have monthly?
- Learn how profitable https://phplab.nz/ is on a monthly basis
- How much does https://www.adhesion.co.nz net monthly?
Analytics and Tracking {📊}
- Google Analytics
- Google Tag Manager
- Google Universal Analytics
Libraries {📚}
- jQuery
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Com/cm/ef49a3f1-d8c1-47d6-88fc-50e41130631f/airgap